IP Library Granted Patent US 8,574,550
Granted Patent B2
US 8,574,550 · App. 13/494,455 · Granted Nov 5, 2013

Biocompatible polymeric contrast agents and radiopaque materials for medical services

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,574,550
App. No.
13/494,455
Granted
Nov 5, 2013
Kind
B2
Abstract

In accordance with the present invention, a high intensity radiopaque contrast agent is disclosed. The agent may be coated on or incorporated within bulk materials, which may then be subsequently utilized to fabricate a radiopaque medical device. Primary effects through chemistry include higher radiopaque concentrations per unit weight of the radiopaque element or agent. Secondary effects include selective placement of the radiopaque elements which may further enhance the radiopacity of the device with reduced requirements of the radiopaque agent. Such a radiopaque contrast agent may be produced in various forms such as a dendrimer and/or incorporated as the end groups of polymeric chain. In addition one can incorporate biological and/or pharmaceutical agents in combination with the present invention.

Claims (22)

1. A compound having the formula:

R—NHFmoc,

wherein R is

and m is an integer between 1 and 3, n is an integer between 0 and 2, and m+n=3, X is a halogen atom selected from Iodine, Bromine and Chlorine.

2. A preferred compound of claim 1 wherein X is Iodine and m is 3 and n is 0.

3. A compound having the formula:

R—NH 2 ,

wherein R is:

and m is an integer between 1 and 3, n is an integer between 0 and 2, and m+n=3, and X is a halogen atom selected from Iodine, Bromine and Chlorine.

4. A compound of claim 3 wherein X is Iodine and m is 3 and n is 0.

5. A compound having the formula:

R—NH—R′,

wherein R is

and m is an integer between 1 and 3, n is an integer between 0 and 2, and m+n=3;

X is a halogen atom selected from Iodine, Bromine and Chlorine; and R′ is a bioabsorbable polymer synthesized via a ring-opening polymerization using R—NH 2 as an initiator.

6. A compound of claim 5 wherein X is Iodine and m is 3 and n is 0.

7. A compound having the formula:

RNH—R′—NHR

wherein R is

and m is an integer between 1 and 3, n is an integer between 0 and 2, and m+n=3, X is a halogen atom selected from Iodine, Bromine and Chlorine, and R′ is a bioabsorbable polymer synthesized via a ring-opening polymerization using R—NH 2 as an initiator and end-capped by RNH 2 through a coupling reaction.

8. A compound of claim 7 wherein X is Iodine and m is 3 and n is 0.

9. A compound of claim 7 where R′ is a copolymer synthesized via a ring-opening polymerization from monomers selected from lactide, glycolide, caprolactone, dioxanone, trimethylene carbonate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →